Newly designed compounds from scaffolds of known actives as inhibitors of survivin: computational analysis from the perspective of fragment-based drug design.
In Silico Pharmacol
; 9(1): 47, 2021.
Article
in En
| MEDLINE
| ID: mdl-34350094
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Prognostic_studies
Language:
En
Journal:
In Silico Pharmacol
Year:
2021
Document type:
Article